U.S. markets open in 7 hours 45 minutes

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
42.53-0.72 (-1.66%)
At close: 4:00PM EDT
Sign in to post a message.
  • P
    Peter
    Canacoord Genuity raised target to $49 reiterated “Buy”, Morgan Stanley raised target to $51 reiterated “Overweight”, Wells Fargo raised target to $50 upgraded to “Overweight”, Deutschland Bank raised target to $45 reiterated “Hold”.
    Bullish
  • P
    Peter
    Edwards Lifesciences beat on Q1 earnings that bodes well for Boston Scientific. Now I understand why that analyst gave Boston Scientific a $52 price target.
  • P
    Peter
    Kaila Krum an analyst at Truist Securities raised its target price for Boston Scientific to $50 from $42 five days ago.
  • P
    Peter
    For the second quarter, Boston Scientific said it sees net sales growing about 46% to 50%, or about 44% to 48% on an organic basis. It expects earnings of 16 cents a share to 18 cents a share, or 36 cents a share to 38 cents a share on an adjusted basis.
  • P
    Peter
    Overall, sales increased 8.2% on a strict as-reported basis to $2.75 billion. Organically, revenue grew 5.9%, Boston Scientific said in a news release. Adjusted profit surged 32.1% to 37 cents per share. Both measures beat forecasts for 31 cents earnings per share and $2.62 billion in sales
  • P
    Peter
    Boston Scientific boosted its full-year guidance. Now, the company forecasts 16%-19% net sales growth and adjusted earnings of $1.53-$1.60 per share. BSX stock analysts called for 16% sales growth and earnings of $1.54 a share
  • P
    Peter
    Analysts at Atlantic Securities set an "overweight" rating and a $52.00 price target on Boston Scientific today.
  • P
    Peter
    For the second quarter, Boston Scientific guided to 46%-50% sales growth and 36-38 cents profit per share. That beat views for adjusted earnings of 35 cents a share and 38% revenue growth.
  • v
    vallien
    If you’re a day trader, you should definitely check out (http://Pick-stocks.com). They send a watchlist covering the top pre-market movers every day before the open. It’s a great way to pick out potential trades for the day.
  • P
    Peter
    BSX stock jumped 4.3% to 44.24. That put BSX stock above a buy point at 42.47 out of a saucer base weekly chart. Boston Scientific stock cleared that entry late last week but dipped below on Monday.
  • P
    Peter
    Nearly 10 million people in the UK are now waiting for surgical procedures, up from 4 million before the pandemic hit. Among them are nearly 100 000 patients whose joint replacement surgeries were cancelled during the first COVID-19 wave, many of whom are left struggling with daily activities because of severe pain and limited mobility. The UK is not alone in this dilemma; a US report projected a backlog of more than 1 million joint and spinal surgeries by mid-2022. Drastic measures will be required to clear these backlogs.
  • R
    Rich
    May break out over the 12/19 - 45 dollar mark - Good sign!
    Bullish
  • T
    Terry
    Nice numbers this AM, be interesting to see how MM's play this one
  • B
    Blas
    Could someone tell me if I should jump in?
    I thought this was a bit undervalued even taking into consideration their debt, but I have been following and I don't know what to do
  • K
    Krishna C
    Surprised to see Yahoo change BSX valuation to 'overvalued'. It was rated undervalued until just yesterday. Waiting for BSX stock to break barrier and reach mid $40's
    Neutral
  • J
    Josh
    It's like riding a bike in first gear, you get nowhere.
  • M
    Minn
    Karen Firestone of Aureus Assets Management, #25 of Forbes Wealth Managers List, recommended Boston Scientific (BSX) as a top pick for 2021 on CNBC’s Halftime Report on 12/31/20. She views it as a Covid vaccine rebound play that has not yet caught up to an eventual post Covid reality. In 2020, she said, patients have delayed “elective” surgeries which will create a pent up demand for their cardiology devices.
    Bullish
  • F
    First
    $40 by the end of the year for sure. Mark my post.
  • D
    Dan
    Bsx partnership with Nvcn or a buyout??
  • G
    Green Machine
    No big deal. Read that EPS will only be affected 1 to 2 cents in 2021. Great buy here! I just picked some up on the dip. Good luck all!
    Bullish